Onset and mortality of Parkinson’s disease in relation to type II diabetes

被引：0
作者：
Gianni Pezzoli
Emanuele Cereda
Paolo Amami
Santo Colosimo
Michela Barichella
Giorgio Sacilotto
Anna Zecchinelli
Michela Zini
Valentina Ferri
Carlotta Bolliri
Daniela Calandrella
Maria Grazia Bonelli
Viviana Cereda
Elisa Reali
Serena Caronni
Erica Cassani
Margherita Canesi
Francesca del Sorbo
Paola Soliveri
Luigi Zecca
Catherine Klersy
Roberto Cilia
Ioannis U. Isaias
机构：
[1] Parkinson Institute Milan,Clinical Nutrition and Dietetics Unit
[2] ASST-Pini-CTO,Clinical Nutrition Unit
[3] Fondazione Grigioni per il Morbo di Parkinson,Programming and Grant Offices (UPGO)
[4] Fondazione IRCCS Policlinico San Matteo,Dietetic and Clinical Nutrition Unit
[5] University of Milan,Department of Parkinson’s Disease, Movement Disorders and Brain Injury Rehabilitation
[6] Specialization School in Nutrition Science,Institute of Biomedical Technologies
[7] ASST-Pini-CTO,Unit of Clinical Epidemiology and Biometry
[8] Italian National Research Council (CNR),Parkinson and Movement Disorders Unit
[9] ASST-Fatebenefratelli-Sacco,Department of Neurology
[10] University Hospital,undefined
[11] “Moriggia-Pelascini” General Hospital,undefined
[12] National Research Council of Italy,undefined
[13] Fondazione IRCCS Policlinico San Matteo,undefined
[14] Fondazione IRCCS Istituto Neurologico Carlo Besta,undefined
[15] University Hospital of Würzburg and Julius Maximilian University of Würzburg,undefined
来源：
Journal of Neurology | 2023年 / 270卷
关键词：
Parkinson’s disease; Diabetes; Age at onset; Prevalence; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1564 / 1572
页数：8
相关论文
共 110 条
[1]  
Tysnes OB(2017)Epidemiology of Parkinson’s disease J Neural Transm 124 901-905
[2]  
Storstein A(2018)The emerging evidence of the Parkinson pandemic J Parkinson’s Dis 8 S3-S8
[3]  
Dorsey ER(2014)The modern pre-levodopa era of Parkinson’s disease: Insights into motor complications from sub-Saharan Africa Brain 137 2731-2742
[4]  
Sherer T(2018)Disease modification in Parkinson’s disease: current approaches, challenges, and future considerations Mov Disord 33 660-677
[5]  
Okun MS(2013)Parkinson’s disease, insulin resistance and novel agents of neuroprotection Brain 136 374-384
[6]  
Bloemd BR(2015)Imaging acetylcholinesterase density in peripheral organs in Parkinson’s disease with 11 C-donepezil PET Brain 138 653-663
[7]  
Cilia R(2020)Enteric cholinergic neuropathy in patients with diabetes: non-invasive assessment with positron emission tomography Neurogastroenterol Motility 119 689-702
[8]  
Akpalu A(2010)Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders Acta Neuropathol 135 877-886
[9]  
Sarfo FS(2018)Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies Acta Neuropathol 315 39-43
[10]  
Lang AE(2012)Dementia is associated with Insulin Resistance in patients with Parkinson’s Disease J Neurol Sci 62 2004-2014
12345678910